Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair
Business / Mobile

Montana’s plan to become an experimental medical hub just pushed forward

Source: mitTechReview July 30, 2026 · 10:10
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Read original article ← Back to Mobile

The original article opens on the publisher's website.

More from Mobile

View topic →